# Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action

> **NCT01439854** · NA · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 18 (actual)

## Conditions studied

- Insulin Sensitivity
- Multiple Mitochondrial Dysfunctions Syndrome

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01439854
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01439854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01439854, "Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01439854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*